Jordanian field hospital in southern Gaza/7 begins providing services
"In fulfillment of Jordan's humanitarian and medical mission to the people of the Gaza Strip, medical teams have begun their work receiving patients and providing medical services, with tremendous medical efforts. We are proud of our presence in the Gaza Strip, working with distinction and efficiency to serve our Palestinian brothers," the hospital force commander said.
For his part, the hospital director explained that the medical and nursing staff have treated more than 1,000 patients in specialized clinics covering a wide range of medical fields, operating around the clock.
The hospital team includes specialists in general surgery, dermatology, vascular surgery, neurosurgery, thoracic surgery, urology, plastic surgery, orthopedics, pediatrics, and maxillofacial surgery. Significantly, the facility also boasts a vital mobile unit dedicated to providing support and prosthetic limbs for amputees.
The hospital teams were accompanied by 11 trucks loaded with humanitarian and relief aid and medical supplies, to provide the hospital with the necessary equipment to perform its duties, as part of the ongoing efforts undertaken by the Jordanian Armed Forces - the Arab Army.
The people of the Gaza Strip expressed their deep gratitude and appreciation to the Hashemite Kingdom of Jordan, under the leadership of His Majesty King Abdullah II Ibn Al Hussein, for its continued support and supportive stances toward the Palestinian people.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Ammon
6 hours ago
- Ammon
Humanin Peptide: Exploring Its Multifaceted Potential Across Research Domains
Ammon News - Humanin is a small, mitochondria-derived peptide consisting of 24 amino acids, first identified in 2001. It has attracted significant attention within the scientific community due to its unique origin and diverse biological activities. Emerging research suggests that Humanin might serve as a pivotal molecule linking mitochondrial function with cellular survival pathways. This article explores the current understanding of Humanin properties and speculates on their prospective uses across various research domains, focusing on their biochemical attributes and the implications of their activity in cellular physiology, cellular aging, metabolic regulation, neurodegeneration, and beyond. Origin and Biochemical Properties of Humanin Humanin is encoded within the mitochondrial 16S ribosomal RNA gene, marking it as a mitochondria-derived peptide (MDP), a class of peptides believed to mediate inter-organelle communication. This origin positions Humanin uniquely as a potential signaling molecule that may support cellular homeostasis. The peptide's sequence is highly conserved across species, indicating an evolutionarily preserved function. Biochemically, Humanin is characterized by its amphipathic nature, allowing it to interact with both hydrophilic and hydrophobic environments. This feature may enable the peptide to cross cellular membranes and interact with intracellular targets, thereby modulating various signaling cascades. Humanin's interaction with specific receptors, including formyl peptide receptor-like 1 (FPRL1) and the ciliary neurotrophic factor receptor (CNTFR) complex, suggests it may trigger intracellular pathways involved in survival and metabolic regulation. Humanin in Mitochondrial Signaling and Cellular Stress Response Mitochondria are crucial regulators of cellular metabolism and apoptotic signaling. It has been hypothesized that Humanin may act as a mitochondrial stress signal, released under conditions of mitochondrial dysfunction. This theory posits that the peptide might serve as an adaptive response element, modulating cell fate decisions during stress. In research contexts, Humanin's possible role may be further investigated as a mediator of mitochondrial quality control and biogenesis. Studies suggest that the peptide might support mitochondrial dynamics by interacting with key proteins involved in fission and fusion processes. These processes are essential for maintaining mitochondrial integrity and function. Given the centrality of mitochondria in numerous diseases and cellular aging, Humanin may serve as a valuable probe for understanding mitochondrial contributions to pathophysiology and organismal longevity. Potential in cellular aging and Longevity Research Cellular aging is characterized by the progressive decline of cellular and organismal function, with mitochondrial dysfunction playing a prominent role. The discovery of Humanin coincided with investigations into the mitochondrial theory of cellular aging, leading to hypotheses that the peptide might modulate age-associated pathways. Research indicates that Humanin levels may decline over time, suggesting a correlation between peptide abundance and organismal integrity. It has been theorized that Humanin may support cellular resistance to oxidative stress and apoptotic stimuli, both of which escalate during cellular aging. Investigations suggest that Humanin may support the activity of longevity regulators, such as AMP-activated protein kinase (AMPK) and sirtuin, thereby contributing to metabolic homeostasis. Moreover, Humanin appears to regulate autophagy, a crucial mechanism for cellular waste removal and recycling. Given that defective autophagy is implicated in age-related diseases, the peptide might serve as a tool for probing autophagic processes and their manipulation to delay cellular aging phenotypes. Humanin's Implications in Neurodegenerative Disease Research Neurodegenerative disorders, including Alzheimer's and Parkinson's diseases, involve complex pathologies where mitochondrial dysfunction, oxidative stress, and apoptosis converge. It has been proposed that Humanin might play a neuroprotective role by interfering with apoptotic pathways activated during neuronal stress. The peptide's interaction with receptors, such as FPRL1, and its support of intracellular signaling pathways may modulate inflammatory responses and cellular survival in neural tissue. Research suggests that Humanin may mitigate the support of toxic protein aggregates, a hallmark of many neurodegenerative conditions, by supporting mitochondrial resilience and reducing oxidative stress. Furthermore, Humanin's potential role in regulating neuroinflammation offers intriguing possibilities for studying the intersection between mitochondrial signals and immune responses within the central nervous system. The peptide may be utilized as a molecular tool in experimental models to dissect pathways implicated in neuronal survival and degeneration. Metabolic Research and Humanin Peptide Metabolic disorders, including diabetes and obesity, have increasingly been linked to mitochondrial dysfunction and impaired inter-organ communication. It has been hypothesized that Humanin may play a role in regulating glucose and lipid metabolism, thereby supporting systemic metabolic homeostasis. Some investigations suggest that Humanin may modulate insulin sensitivity and mitochondrial bioenergetics, supporting energy balance at the cellular and organismal levels. Studies suggest that the peptide may interact with signaling networks, such as the PI3K/Akt pathway, which plays a central role in metabolic control. Given its mitochondrial origin, Humanin may serve as a key signaling molecule in the crosstalk between mitochondria and other cellular organelles, such as the endoplasmic reticulum, further supporting metabolic processes. These properties position Humanin as a promising candidate for research into the molecular underpinnings of metabolic diseases and the development of novel metabolic modulators. Cardiovascular and Vascular Research Potential Emerging data indicate that Humanin might exert support on vascular cells and cardiovascular function. The peptide's interaction with endothelial cells suggests a role in regulating vascular tone and inflammatory responses within blood vessels. It is theorized that Humanin might support mitochondrial function in cardiomyocytes and vascular smooth muscle cells, possibly modulating cellular survival under ischemic or oxidative stress conditions. These properties have prompted investigations into the peptide's potential to support mechanisms underlying atherosclerosis and other vascular pathologies. As mitochondrial dysfunction is increasingly studied as a contributor to the progression of cardiovascular disease, Humanin may serve as a novel research molecule for dissecting mitochondrial involvement in vascular integrity and disease. Future Directions and Research Challenges Despite growing interest, much remains speculative about the full scope of Humanin's possible roles and mechanisms. It has been proposed that further elucidation of Humanin's receptor interactions, signaling pathways, and intracellular targets is necessary to unlock its research potential fully. Technological advances in mitochondrial biology, peptide synthesis, and receptor pharmacology may facilitate the development of experimental tools to explore Humanin's activities in greater detail. Additionally, the integration of omics technologies, such as proteomics and metabolomics, may provide comprehensive insights into the peptide's support on cellular networks. Conclusion Humanin represents a fascinating intersection of mitochondrial biology, cellular signaling, and organismal physiology. Its properties as a mitochondria-derived peptide position it uniquely as a molecule of interest across multiple research domains, including cellular aging, neurodegeneration, metabolism, cardiovascular science, and immunology. While many aspects of Humanin's function remain hypothetical, ongoing investigations suggest it might serve as a crucial mediator of mitochondrial communication and cellular resilience. Continued exploration of this peptide may not only deepen understanding of mitochondrial roles in science and disease but also unveil novel pathways for scientific inquiry. Visit this website for the best research compounds.
Jordan News
9 hours ago
- Jordan News
Hikma Pharmaceuticals Donates $1.1 Million in Medical Aid to Syria - Jordan News
Hikma Pharmaceuticals PLC (Hikma) has donated $1.1 million worth of emergency medical supplies to Syria as part of a humanitarian initiative launched under royal directives and implemented by the Jordan Hashemite Charity Organization (JHCO). اضافة اعلان The medical convoy included essential medications such as antibiotics, painkillers, and a range of oral and hospital-use drugs, aimed at alleviating the acute shortage of medical supplies in Syria. This contribution reflects Hikma's ongoing commitment to its social and humanitarian responsibilities and its vision of delivering "better health, within reach, every day." The initiative builds on Hikma's longstanding support for relief and medical efforts both in Jordan and abroad, reinforcing its leadership as a Jordanian-based pharmaceutical company dedicated to serving communities and strengthening health systems especially in times of crisis and disaster.C
Roya News
15 hours ago
- Roya News
Jordan dispatches large aid convoys to Gaza
Large Jordanian aid convoys are on the move toward the Gaza Strip, carrying essential food and medical supplies – according to a statement by the authorities. The Public Security Directorate (PSD) Radio reported the convoys are part of Jordan's ongoing efforts to provide humanitarian support and alleviate the suffering of the Palestinian people in Gaza. The convoys, laden with food and medical necessities, will head to Gaza via designated border crossings. More aid shipments are expected in the coming days, the statement added.
